COVID-19 vaccine intentions in Australia.
作者信息
Pickles Kristen, Copp Tessa, Dodd Rachael H, Cvejic Erin, Seale Holly, Steffens Maryke S, Meyerowitz-Katz Gideon, Bonner Carissa, McCaffery Kirsten
机构信息
Faculty of Medicine and Health, Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Faculty of Medicine and Health, Sydney Health Literacy Lab, School of Public Health, The University of Sydney, Sydney, NSW, Australia.
出版信息
Lancet Infect Dis. 2021 Dec;21(12):1627-1628. doi: 10.1016/S1473-3099(21)00686-1.
Abstract
摘要
相似文献
1
COVID-19 vaccine intentions in Australia.
Lancet Infect Dis. 2021 Dec;21(12):1627-1628. doi: 10.1016/S1473-3099(21)00686-1.
2
COVID-19 vaccine intentions in Australia.
Lancet Infect Dis. 2021 Dec;21(12):1628-1629. doi: 10.1016/S1473-3099(21)00694-0.
3
Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine.
BMC Infect Dis. 2021 Jan 28;21(1):120. doi: 10.1186/s12879-021-05833-1.
4
COVID-19 Australia: Epidemiology Report 38 Reporting period ending 28 March 2021.
Commun Dis Intell (2018). 2021 Apr 9;45. doi: 10.33321/cdi.2021.45.19.
5
Willingness to vaccinate against COVID-19 in Australia.
Lancet Infect Dis. 2021 Mar;21(3):318-319. doi: 10.1016/S1473-3099(20)30559-4. Epub 2020 Jun 30.
6
COVID-19 Australia: Epidemiology Report 41: Reporting period ending 9 May 2021.
Commun Dis Intell (2018). 2021 May 17;45. doi: 10.33321/cdi.2021.45.26.
7
COVID-19 Australia: Epidemiology Report 40: Reporting period ending 25 April 2021.
Commun Dis Intell (2018). 2021 May 25;45. doi: 10.33321/cdi.2021.45.25.
8
COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
Immunity. 2021 Jul 13;54(7):1353-1362. doi: 10.1016/j.immuni.2021.06.017.
9
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
10
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
引用本文的文献
1
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.
Eur J Neurol. 2023 Feb;30(2):463-473. doi: 10.1111/ene.15602. Epub 2022 Nov 2.
2
Understandings and practices related to risk, immunity and vaccination during the Delta variant COVID-19 outbreak in Australia: An interview study.
Vaccine X. 2022 Aug;11:100183. doi: 10.1016/j.jvacx.2022.100183. Epub 2022 Jun 13.
3
COVID-19 Vaccine Misperceptions in a Community Sample of Adults Aged 18-49 Years in Australia.
Int J Environ Res Public Health. 2022 Jun 4;19(11):6883. doi: 10.3390/ijerph19116883.
4
Predictors of confidence and trust in government and institutions during the COVID-19 response in Australia.
Lancet Reg Health West Pac. 2022 May 31;23:100490. doi: 10.1016/j.lanwpc.2022.100490. eCollection 2022 Jun.
本文引用的文献
1
Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia.
Vaccine. 2022 Apr 14;40(17):2484-2490. doi: 10.1016/j.vaccine.2021.08.007. Epub 2021 Aug 5.
2
Concerns and motivations about COVID-19 vaccination.
Lancet Infect Dis. 2021 Feb;21(2):161-163. doi: 10.1016/S1473-3099(20)30926-9. Epub 2020 Dec 15.
3
COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II.
Psychol Med. 2022 Oct;52(14):3127-3141. doi: 10.1017/S0033291720005188. Epub 2020 Dec 11.
4
Willingness to vaccinate against COVID-19 in Australia.
Lancet Infect Dis. 2021 Mar;21(3):318-319. doi: 10.1016/S1473-3099(20)30559-4. Epub 2020 Jun 30.
Zotero 插件